Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX2CPR
|
||||
| Drug Name |
3-[4-(4-Chloro-phenyl)-piperazin-1-yl]-1-phenyl-propan-1-one oxime
|
||||
| Synonyms |
CHEMBL134805
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H22ClN3O
|
||||
| Canonical SMILES |
O\\N=C(/CCN1CCN(CC1)c2ccc(Cl)cc2)\\c3ccccc3
|
||||
| InChI |
InChI=1S/C19H22ClN3O/c20-17-6-8-18(9-7-17)23-14-12-22(13-15-23)11-10-19(21-24)16-4-2-1-3-5-16/h1-9,24H,10-15H2/b21-19+
|
||||
| InChIKey |
FMFYWCUXOKUXQN-XUTLUUPISA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.